Go Pro
→ Trump goes 'all-in' on Grand Canyon energy breakthrough (From Behind the Markets) (Ad)tc pixel
OTCMKTS:SKVI

Skinvisible Q4 2024 Earnings Report

$0.20 +0.00 (+0.55%)
As of 03:58 PM Eastern
ProfileEarnings History

Skinvisible EPS Results

Actual EPS
$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Skinvisible Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Skinvisible Announcement Details

Quarter
Q4 2024
Date
4/14/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Skinvisible Earnings Headlines

SKINVISIBLE INC by Skinvisible, Inc. Insider Trading Activity | OTC:SKVI | Benzinga
May 17, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SKVI/insider-trades
Skinvisible Inc.
May 11, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/SKVI/financials
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter. Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion. A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations.tc pixel
September 28 at 1:00 AM  |  Monument Traders Alliance (Ad)
Skinvisible Stock Price History
October 9, 2025  |  investing.comhttps://www.investing.com/equities/skinvisible-inc-historical-data
Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments ...
September 19, 2025  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OVATF/pressreleases/34883721/ovation-science-and-skinvisible-pharmaceuticals-enhance-their-strategic-partnership-in-the-obesity-market-with-innovative-cannabinoid-delivery-technology-with-new-developments-and-patent-protection/
Skinvisible Delays 10-K Filing Due to Compilation Issues
March 31, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/skinvisible-delays-10-k-filing-due-to-compilation-issues?utm_source=marketbeat.com&utm_medium=referral
See More Skinvisible Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Skinvisible? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Skinvisible and other key companies, straight to your email.

About Skinvisible

Skinvisible (OTCMKTS:SKVI), Inc. is a specialty healthcare and personal-care company focused on developing topical products and delivery technologies. Its principal technology, Invisicare, is a polymer-based delivery system designed to help keep active ingredients on the skin and improve the performance and usability of topical formulations.

The company has pursued applications for Invisicare in pharmaceutical, cosmetic, antimicrobial, wound-care and personal-care products. Its activities have included developing products internally and working with commercial partners to formulate, license or distribute topical treatments and skin-care products.

Skinvisible has historically operated from the United States and has been described as a development-stage company. Publicly available information about its current operations, product availability, geographic reach and leadership is limited, so the company’s present business status and management structure cannot be described reliably.

View Skinvisible Profile
Earnings Tools